1 |
Bursavich MG, Rich DH. Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles. J Med Chem. 2002;45:541-58.
DOI
|
2 |
Byun HG, Kim YT, Park PJ, Lin X, Kim SK. Chitooligosaccharides as a novel - secretase inhibitor. Carbohyd Polym. 2005;61:198-202.
DOI
|
3 |
Chen J, Suetsuna K, Yamauchi F. Isolation and characterization of immunostimulative peptides from soybean. J Nutr Biochem. 1995;6:310-3.
DOI
|
4 |
Cheung IWY, Li-Chan ECY. Angiotensin-I-converting enzyme inhibitory activity and bitterness of enzymatically-produced hydrolysates of shrimp (Pandalopsis dispar) processing byproducts investigated by Taguchi design. Food Chem. 2010;122:1003-12.
DOI
|
5 |
Cheung LKY, Cheung IWY, Li-Chan ECY. Effects of production factors and egg-bearing period on the antioxidant activity of enzymatic hydrolysates from shrimp (Pandalopsis dispar) processing byproducts. J Agric Food Chem. 2012;60:6823-31.
DOI
|
6 |
Citron M. Beta-secretase inhibition for the treatment of Alzheimer's disease-promise and challenge. Trends Pharmacol Sci. 2004;25:92-7.
DOI
|
7 |
Cumming JN, Iserloh U, Kennedy ME. Design and development of -secretase inhibitors. Curr Opin Drug Disc Devel. 2004;7:536-56.
|
8 |
Dey SS, Dora KC. Antioxidative activity of protein hydrolysate produced by alcalase hydrolysis from shrimp waste (Penaeus monodon and Penaeus indicus). J Food Sci Tech. 2014;51:449-57.
DOI
|
9 |
He HL, Chen XL, Wu H, Sun CY, Zhang ZY, Zhou BC. High throughput and rapid screening of marine protein hydrolysates enriched in peptides with angiotensin-I-converting enzyme inhibitory activity by capillary electrophoresis. Bioresource Technol. 2007;98:3499-505.
DOI
|
10 |
Hong L, He X, Huang X, Chang W, Tang J. Structural features of human memapsin 2 (beta-secretase) and their biological and pathological implications. Acta Biochim Biophys Sin. 2005;36:787-92.
|
11 |
Johnston JA, Liu WW, Coulson DTR, Todd S, Murphy S, Brennan S. Platelet -secretase activity is increased in Alzheimer' disease. Neurobiol Aging. 2008;29:661-8.
DOI
|
12 |
Kimura R, Devi L, Ohno M. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. J Neurochem. 2010;113:248-61.
DOI
|
13 |
Kwak HM, Jeon SY, Song BH, Kim JG, Lee JM, Lee KB, Jeong HH, Hur J M, Kang YH, Song KS. -Secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch Pharm Res. 2005;28:1328-32.
DOI
|
14 |
Lee DH, Lee DH, Lee JS. Characterization of a new antidementia -secretase inhibitory peptide from Saccharomyces cerevisiae. Enzyme Microb Tech. 2007;42:83-8.
DOI
|
15 |
Lee HJ, Seong YH, Bae KH, Kwon SH, Kwak HM, Nho SK, Kim KA, Hur JM, Lee KB, Kang YH, Song KS. -secretase (BACE1) inhibitors from Sanguisorbae radix. Arch Pharm Res. 2011;28:799-803.
|
16 |
McLay RN, Pan W, Kastin AJ. Effects of peptides on animal and human behavior. Peptides. 2001;22:2181-255.
DOI
|
17 |
Mendis E, Rajapakse N, Kim SK. Antioxidant properties of a radicals scavenging peptide purified from enzymatically prepared fish skin gelatin hydrolysate. J Agr Food Chem. 2005;53:581-7.
DOI
|
18 |
Park IH, Jeon SY, Lee HJ, Kim SI, Song KS. A -secretase (BACE1) inhibitor hispidinfrom the mycelial cultures of Phellinuslinteus. Planta Med. 2004;70:143-6.
DOI
|
19 |
Stachel SJ, Coburn CA, Steele TG, Jones KG, Loutzenhiser EF, Gregro AR. Structure-based design of potent and selective cellpermeable inhibitors of human -secretase (BACE-1). J ACS Med Chem Lett. 2004;47:6447-50.
|
20 |
Turner RT, Koelsch G, Hong L, Castanheira P, Ermolieff J, Ghosh AK. Subsite specificity of memapsin 2 ( -secretase): implications for inhibitor design. Biochem. 2001;40:10001-6.
DOI
|
21 |
World Health Organization and Alzheimer's Disease International. Dementia: a public health priority. World Health Organization, 2012.
|